Last edition
News about "sNDA"
IntraBio Submits sNDA for Levacetylleucine in Ataxia-Telangiectasia
IntraBio has submitted an sNDA to the US Food and Drug Administration (FDA) for Levacetylleucine, marking the first regulatory filing seeking approval for the treatment of Ataxia-Telangiectasia.
SNDA | 21/03/2026 | By News Bureau
China's NMPA Accepts Akeso's Gumukimab sNDa for Ankylosing Spondylitis
China’s NMPA gives approval to Akeso’s gumokimab for the treatment of active ankylosing spondylitis, supported by Phase III data showing significant symptom relief and functional improvement.
SNDA | 20/01/2026 | By News Bureau | 232
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy